Composition
- Active ingredients
- CEFAMANDOLE NAFATE EQ 2GM BASE/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CEFAMANDOLE NAFATE EQ 500MG BASE/VIAL · InjectableNDA050504-001 · Discontinued
- CEFAMANDOLE NAFATE EQ 10GM BASE/VIAL · InjectableNDA050504-004 · Discontinued
- CEFAMANDOLE NAFATE EQ 1GM BASE/VIAL · InjectableNDA050504-002 · Discontinued
- CEFAMANDOLE NAFATE EQ 2GM BASE/VIAL · InjectableNDA050504-003 · Discontinued
- CEFAMANDOLE NAFATE EQ 1GM BASE/VIAL · InjectableANDA062560-001 · Discontinued
- CEFAMANDOLE NAFATE EQ 2GM BASE/VIAL · InjectableThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA062560.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Mandol
- Active substance
- cefamandole nafate
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Lilly
- Status
- Discontinued
- FDA approval
- 10 Sept 1985
- Application
- ANDA062560-002